Authors
Loading...
Scoping review demonstrates high-throughput DNA technologies improve screening for newborn conditions, suggesting further integration into programs.
Fabella et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: